Guided Tour
 View Your Account
 Shop for Stocks
 Research Stocks
 Educate Yourself
 Family Investing
 Retirement Focus
 Our Strategy
 About Us
 Helpdesk
 Home
Google Custom Search
 
Symbol Lookup
Profile
HBIO - Harvard Bioscience Inc (NASDAQ GM) 12:00 AM ET, 12/17/2014 
 Last: 4.80 Change: +0.08 %Change: +1.69% Volume: 35,700  
Detailed QuoteSEC FilingsProfileNewsChart
Harvard Bioscience Inc (NASDAQ GM:HBIO)
84 October Hill Road
Holliston, MA 01746
Phone: (508) 893-8999
Fax: (508) 429-5732
http://www.harvardbioscience.com
Harvard Bioscience, Inc. a Delaware corporation began in 1901. The Company is a developer, manufacturer and marketer of specialized products, like apparatus and scientific instruments, used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories. It has sales and manufacturing operations in the United States, the United Kingdom, Germany and Spain and sales facilities in France and Canada. It sells its products to researchers in over 100 countries mainly through its sales organization, catalog, website, distributors like GE Healthcare, Thermo Fisher Scientific Inc. and VWR, and via its field sales organization. Today, its broad product range is generally targeted towards two application areas; ADMET testing and molecular biology and liquid handling. ADMET Testing - The ADMET testing identifies compounds that have toxic side effects or undesirable physiological or pharmacological properties. It has products that its customers use to help their researchers conduct experiments on cells, tissues, organs and animals. The Company sells these products under the brand names including Harvard Pumps, Harvard Apparatus, Denville, Biochrom, Warner Instruments, BTX, KD Scientific, Hugo Sachs Elektronik, Panlab, Coulbourn Instruments, and CMA Microdialysis. These products are mainly scientific instruments such as spectrophotometers and plate readers that analyze light to detect and quantify molecular and cellular processes or apparatus such as gel electrophoresis units. The Company's end-user customers are mainly research scientists at pharmaceutical and biotechnology companies, universities and government laboratories, including the U.S. National Institutes of Health, or NIH. The Company's academic customers have included colleges and universities such as Baylor University, Cambridge University, Harvard University, Johns Hopkins University, Massachusetts Institute of Technology, Yale University and the University of Texas - MD Anderson Center. The Company's pharmaceutical and biotechnological customers have included pharmaceutical companies and research laboratories such as Amgen, Inc., AstraZeneca plc, Genentech, Inc. and Johnson & Johnson. It competes with several companies that provide instruments for life science research including, Amaxa GmbH, Becton Dickinson, Eppendorf AG, Kent Scientific Corporation, Razel Scientific Instruments, Inc., Ugo Basile, Danaher Corporation, Bio-Rad Laboratories, Inc., MDS Analytical Technologies, PerkinElmer, Inc. and Thermo Fisher Scientific, Inc. The Company is not subject to direct governmental regulation other than the laws and regulations generally applicable to businesses in the domestic and foreign jurisdictions in which it operates.
 Sector:Biotechnology 
 Number of Employees:345 
 Share Information
 Shares
 Outstanding:
32.4M 
 Market Cap:155.6M 
 Cash Flow (per sh):0.17 
 Book Value:2.99 
 Fundamentals
 EPS:0.06 
 P/E Ratio:80.00 
 Dividend:0.00 
 Yield:0.00 
 Management Effectiveness
 Return on Equity (1 year):1.70 
 Return on Assets (1 year):1.20 
 Return on Investment (1 year):1.40 
 Performance
 52wk High
 (12/23/2013):
5.15 
 52wk Low
 (6/25/2014):
3.68 
 Key Financials
Revenue Total Net Income Earnings/Share EBITDA Long Term Debt 
 2013$105.2M $-1.8M $-0.06 $9.8M $19.8M 
 2012$111.2M $2.4M $0.08 $13.1M $13.0M 



Quotes delayed at least 15 minutes. Market data provided by Interactive Data.
Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.
Fundamental data provided by Morningstar, Inc.


BUYandHOLD does not offer or provide any investment advice or opinion regarding the nature, potential, value, suitability or profitability of any particular security, portfolio of securities, transaction or investment strategy. Any investment decisions you make will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs. The security and information listed above and is being provided for informational purposes only and should not be regarded as an offer to sell or as a solicitation of an offer to buy and past performance is no guarantee of future results.

The BUYandHOLD website contains links to third-party websites on the Internet. BUYandHOLD provides these links to these websites only as a convenience to users of the website. Links on the BUYandHOLD website are not endorsements by BUYandHOLD or Freedom Investments, implied or express, of the linked sites or any products, services or links in such sites; and no information in such sites has been endorsed or approved by BUYandHOLD. Linked sites are not under the control of BUYandHOLD or Freedom Investments, and we are not responsible for the contents of any linked site or any link contained in a linked site. No information contained in the BUYandHOLD website or accessed through any linked site, or any link contained in a linked site, constitutes a recommendation by BUYandHOLD or Freedom Investments to buy, sell or hold any security, financial product or instrument. Information accessed through linked sites is not, nor should be construed as, an offer or a solicitation of an offer, to buy or sell securities by BUYandHOLD or Freedom Investments. BUYandHOLD does not offer or provide any investment advice or opinion regarding the nature, potential, value, suitability or profitability of any particular security, portfolio of securities, transaction or investment strategy, and any investment decisions you make will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs.

Copyright © 1999 – 2014 Freedom Investments. All Rights Reserved.
Freedom Investments, Inc. Member FINRA/SIPC
Privacy & Security